Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7912
-0.0062 (-0.78%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7820
-0.0092 (-1.16%)
After-hours: Mar 16, 2026, 7:39 PM EDT
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
$32,932
Profits / Employee
-$72,521
Market Cap
6.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | 131 | -12 | -8.39% | 131 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| Bolt Biotherapeutics | 40 |
| Moleculin Biotech | 17 |
| Dogwood Therapeutics | 12 |
| Processa Pharmaceuticals | 10 |
| Mustang Bio | 6 |
| PharmaCyte Biotech | 2 |
| SciSparc | 2 |
EVGN News
- 3 days ago - Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus
- 3 days ago - Q4 2025 Evogene Ltd Earnings Call Transcript - GuruFocus
- 7 days ago - Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - PRNewsWire
- 11 days ago - Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Evogene (EVGN) Focuses on Key Markets Following Strategic Shift - GuruFocus
- 11 days ago - Evogene Earnings Review: Q4 Summary - Benzinga
- 11 days ago - Evogene Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 12 days ago - An Overview of Evogene's Earnings - Benzinga